Chemotherapy Before Autologous Stem Cell Transplantation +/- Rituximab in Relapsed or Refractory Aggressive Non-Hodgkin's Lymphoma

NCT00078949 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

849

Enrollment

NETWORK

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: rituximab
DRUG: cisplatin
DRUG: cytarabine
DRUG: dexamethasone
DRUG: gemcitabine hydrochloride

Sponsor

NCIC Clinical Trials Group